ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/11 | 2,304 | 2,361 | 2,271 | 2,333 | +29 | +1.3% | 1,276,200 |
2022/01/07 | 2,415 | 2,429 | 2,240 | 2,304 | -116 | -4.8% | 2,553,500 |
2022/01/06 | 2,512 | 2,524 | 2,412 | 2,420 | -142 | -5.5% | 1,392,700 |
2022/01/05 | 2,541 | 2,613 | 2,520 | 2,562 | +29 | +1.1% | 1,256,100 |
2022/01/04 | 2,552 | 2,568 | 2,477 | 2,533 | -12 | -0.5% | 1,100,800 |
2021/12/30 | 2,631 | 2,631 | 2,521 | 2,545 | -108 | -4.1% | 1,414,200 |
2021/12/29 | 2,645 | 2,715 | 2,641 | 2,653 | +19 | +0.7% | 777,400 |
2021/12/28 | 2,658 | 2,692 | 2,591 | 2,634 | -40 | -1.5% | 1,182,900 |
2021/12/27 | 2,800 | 2,800 | 2,663 | 2,674 | -113 | -4.1% | 893,600 |
2021/12/24 | 2,817 | 2,843 | 2,771 | 2,787 | -19 | -0.7% | 838,200 |
2021/12/23 | 2,817 | 2,845 | 2,746 | 2,806 | -111 | -3.8% | 2,196,800 |
2021/12/22 | 2,908 | 2,929 | 2,841 | 2,917 | +5 | +0.2% | 1,415,800 |
2021/12/21 | 2,761 | 2,944 | 2,724 | 2,912 | +185 | +6.8% | 2,456,900 |
2021/12/20 | 2,748 | 2,848 | 2,721 | 2,727 | +109 | +4.2% | 2,861,400 |
2021/12/17 | 2,700 | 2,729 | 2,607 | 2,618 | -67 | -2.5% | 1,424,200 |
2021/12/16 | 2,715 | 2,724 | 2,666 | 2,685 | +70 | +2.7% | 828,600 |
2021/12/15 | 2,690 | 2,696 | 2,595 | 2,615 | -89 | -3.3% | 775,900 |
2021/12/14 | 2,753 | 2,796 | 2,695 | 2,704 | -85 | -3% | 817,900 |
2021/12/13 | 2,774 | 2,810 | 2,715 | 2,789 | +10 | +0.4% | 719,200 |
2021/12/10 | 2,765 | 2,816 | 2,747 | 2,779 | +7 | +0.3% | 1,000,400 |
2021/12/09 | 2,730 | 2,824 | 2,711 | 2,772 | +29 | +1.1% | 971,300 |
2021/12/08 | 2,699 | 2,780 | 2,671 | 2,743 | +126 | +4.8% | 1,484,400 |
2021/12/07 | 2,623 | 2,655 | 2,580 | 2,617 | -5 | -0.2% | 1,130,300 |
2021/12/06 | 2,676 | 2,740 | 2,591 | 2,622 | -62 | -2.3% | 1,453,400 |
2021/12/03 | 2,800 | 2,833 | 2,632 | 2,684 | -166 | -5.8% | 2,622,000 |
2021/12/02 | 2,698 | 2,884 | 2,698 | 2,850 | +154 | +5.7% | 2,429,000 |
2021/12/01 | 2,849 | 2,850 | 2,681 | 2,696 | -166 | -5.8% | 2,631,800 |
2021/11/30 | 2,838 | 2,895 | 2,735 | 2,862 | -18 | -0.6% | 12,202,500 |
2021/11/29 | 2,766 | 2,935 | 2,766 | 2,880 | +64 | +2.3% | 2,475,100 |
2021/11/26 | 2,739 | 2,824 | 2,720 | 2,816 | -23 | -0.8% | 1,475,100 |
2021/11/25 | 2,823 | 2,862 | 2,750 | 2,839 | +45 | +1.6% | 1,370,300 |
2021/11/24 | 2,794 | 2,830 | 2,708 | 2,794 | -147 | -5% | 2,483,300 |
2021/11/22 | 2,730 | 2,965 | 2,712 | 2,941 | +236 | +8.7% | 2,569,000 |
2021/11/19 | 2,865 | 2,867 | 2,690 | 2,705 | -174 | -6% | 2,053,300 |
2021/11/18 | 2,877 | 2,945 | 2,845 | 2,879 | -14 | -0.5% | 1,196,000 |
2021/11/17 | 2,926 | 2,926 | 2,837 | 2,893 | -49 | -1.7% | 1,369,500 |
2021/11/16 | 2,900 | 2,969 | 2,819 | 2,942 | +11 | +0.4% | 1,701,800 |
2021/11/15 | 2,830 | 2,986 | 2,828 | 2,931 | +101 | +3.6% | 2,133,200 |
2021/11/12 | 2,674 | 2,839 | 2,668 | 2,830 | +306 | +12.1% | 3,041,100 |
2021/11/11 | 2,510 | 2,562 | 2,487 | 2,524 | -17 | -0.7% | 1,011,700 |
2021/11/10 | 2,550 | 2,599 | 2,516 | 2,541 | -29 | -1.1% | 1,042,000 |
2021/11/09 | 2,685 | 2,689 | 2,561 | 2,570 | -90 | -3.4% | 1,268,700 |
2021/11/08 | 2,800 | 2,812 | 2,626 | 2,660 | -180 | -6.3% | 1,535,200 |
2021/11/05 | 2,800 | 2,846 | 2,756 | 2,840 | +56 | +2% | 1,183,400 |
2021/11/04 | 2,803 | 2,825 | 2,678 | 2,784 | +1 | ±0% | 1,504,600 |
2021/11/02 | 2,800 | 2,894 | 2,775 | 2,783 | -16 | -0.6% | 1,621,100 |
2021/11/01 | 2,765 | 2,839 | 2,762 | 2,799 | +46 | +1.7% | 1,140,900 |
2021/10/29 | 2,727 | 2,767 | 2,682 | 2,753 | -12 | -0.4% | 1,192,000 |
2021/10/28 | 2,655 | 2,830 | 2,650 | 2,765 | +111 | +4.2% | 1,922,300 |
2021/10/27 | 2,714 | 2,732 | 2,599 | 2,654 | -100 | -3.6% | 2,000,200 |
801~
850
件表示中 / 2897件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 181,500円 | +5.0% | +1.5% | 0.00% | 15.58倍 | 4.14倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 356,700円 | +7.9% | +8.9% | 3.48% | 7.63倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 60,800円 | +21.1% | - | 0.00% | 15.10倍 | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 402,000円 | +30.5% | +111.0% | 4.73% | 11.33倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 359,500円 | +14.5% | -2.3% | 2.50% | 13.15倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム